JGLYX
Price
$18.92
Change
-$0.39 (-2.02%)
Updated
Feb 3 closing price
Net Assets
2.48B
VISGX
Price
$88.41
Change
+$2.93 (+3.43%)
Updated
Feb 3 closing price
Net Assets
39.31B
Interact to see
Advertisement

JGLYX vs VISGX

Header iconJGLYX vs VISGX Comparison
Open Charts JGLYX vs VISGXBanner chart's image
JPMorgan Small Cap Growth R4
Price$18.92
Change-$0.39 (-2.02%)
VolumeN/A
Net Assets2.48B
Vanguard Small Cap Growth Index I
Price$88.41
Change+$2.93 (+3.43%)
VolumeN/A
Net Assets39.31B
JGLYX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
JGLYX vs. VISGX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGLYX is a StrongBuy and VISGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 39.3B vs. JGLYX (2.48B). VISGX pays higher dividends than JGLYX: VISGX (0.41) vs JGLYX (0.17). JGLYX was incepted earlier than VISGX: JGLYX (9 years) vs VISGX (28 years). JGLYX (1.00) is less costly to investors than VISGX (0.19). JGLYX is a more actively managed with annual turnover of: 48.00 vs. VISGX (21.00). JGLYX has a lower initial minimum investment than VISGX: JGLYX (0) vs VISGX (3000). VISGX annual gain was more profitable for investors over the last year : 8.90 vs. JGLYX (0.57). VISGX return over 5 years is better than : 9.24 vs. JGLYX (-31.10).
JGLYXVISGXJGLYX / VISGX
Total Expense Ratio0.990.19521%
Annual Report Gross Expense Ratio1.000.19526%
Fund Existence9 years28 years-
Gain YTD5.5804.171134%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B39.3B6%
Annual Yield % from dividends0.170.4142%
Returns for 1 year0.578.906%
Returns for 3 years18.7737.1451%
Returns for 5 years-31.109.24-337%
Returns for 10 yearsN/A204.50-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIVRX35.940.48
+1.35%
Thornburg International Equity R5
CVMRX25.310.28
+1.12%
Calvert Emerging Markets Equity R6
MBXBF0.16N/A
N/A
Microbix Biosystems Inc.
FRACF2.14N/A
N/A
Foraco International, Marseille
BRWUX27.17-0.51
-1.84%
MFS Blended Research Growth Eq R4